BioSpace News Archive

Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced that Sheila Hopkins will be joining its Board of Directors, effective immediately.

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended March 31, 2021.

ReShape Lifesciences Inc., a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, reported its financial and operational results for the three months ended March 31, 2021.

Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2021.

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided a corporate and commercial update.

SWK Holdings Corporation, a life sciences focused specialty finance company catering to small and mid-sized companies, provided a business update and announced its financial and operating results for the first quarter ended March 31, 2021.

In a move destined to shape the global growth and evolution of the medicinal cannabinoid industry, medicinal cannabis horticultural company Bioarc Ltd. is joining forces with specialty drug development and manufacturing company Santé Laboratories to develop a portfolio of highly bioavailable whole plant therapeutic products.

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases, today announced financial results for the first quarter ended March 31, 2021.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the first quarter of 2021 and provided a business update.

Throughout the COVID-19 pandemic, Canadians have looked to the Public Health Agency of Canada to provide public health guidance and leadership.